This Article Full Text Full Text (PDF) All Versions of this Article: 90/2/712    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laaksonen, D. E. Articles by Salonen, J. T. Search for Related Content PubMed PubMed Citation Articles by Laaksonen, D. E. Articles by Salonen, J. T. Related Collections Diabetes and Insulin Male Endocrinology

The Metabolic Syndrome and Smoking in Relation to Hypogonadism in Middle-Aged Men: A Prospective Cohort Study

Departments of Medicine (D.E.L., L.N.) and Clinical Chemistry (K.P.), Kuopio University Hospital, Kuopio, Finland; Research Institute of Public Health (K.N., T.-P.T., V.-P.V., J.T.S.), Departments of Physiology (D.E.L.) and Public Health and General Practice (J.T.S.), University of Kuopio, FIN-70211 Kuopio, Finland; and Oy Jurilab Ltd. (J.T.S.), FIN-70211 Kuopio, Finland

Address all correspondence and requests for reprints to: Kristiina Nyyssönen, Ph.D., Research Institute of Public Health, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland. E-mail: Kristiina. Nyyssonen{at}uku.fi.

In men, hypoandrogenism is associated with features of the metabolic syndrome. It is not known whether men with the metabolic syndrome are at a higher risk of developing hypogonadism. We therefore assessed whether the metabolic syndrome predicts development of hypogonadism 11 yr later in 651 middle-aged Finnish men participating in a population-based cohort study. Men with the metabolic syndrome at baseline as defined by the World Health Organization (n = 114, 20%) had a 2.6-fold increased risk of developing hypogonadism as defined by total testosterone levels less than 11 nmol/liter at the 11-yr follow-up independent of age, smoking, and other potential confounders. Further adjustment for body mass index (OR, 2.0; 95% CI, 1.1–3.8) or baseline total testosterone levels (OR, 1.9; 95% CI, 1.0–3.4) attenuated the association. The association of the metabolic syndrome with hypogonadism as defined by calculated free testosterone levels less than 225 pmol/liter was similar, but weaker. The adjusted decrease in testosterone concentrations during the 11-yr follow-up was also greater in men with than without the metabolic syndrome. Smokers had a nonsignificantly lower risk of developing hypogonadism during follow-up, whereas a decrease in smoking increased the risk of hypogonadism. The metabolic syndrome predisposes to development of hypogonadism in middle-aged men. Prevention of abdominal obesity and the accompanying metabolic syndrome in middle age may decrease the risk of hypogonadism in men, especially in those who quit smoking.

This article has been cited by other articles:

				C. A. Bondy Endogenous sex hormones and type 2 diabetes risk. JAMA, July 12, 2006; 296(2): 169 - 169. [Full Text] [PDF]

				E. Orwoll, L. C. Lambert, L. M. Marshall, K. Phipps, J. Blank, E. Barrett-Connor, J. Cauley, K. Ensrud, S. Cummings, and for the Osteoporotic Fractures in Men Study Group Testosterone and Estradiol among Older Men J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1336 - 1344. [Abstract] [Full Text] [PDF]

				S. Kurl, J. A. Laukkanen, L. Niskanen, D. Laaksonen, J. Sivenius, K. Nyyssonen, and J. T. Salonen Metabolic Syndrome and the Risk of Stroke in Middle-Aged Men Stroke, March 1, 2006; 37(3): 806 - 811. [Abstract] [Full Text] [PDF]